Literature DB >> 7705216

Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use.

J Cashman1, G McAnulty.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of agents with similar actions but diverse chemical structures. Aspirin (acetylsalicylic acid) and sodium salicylate were the first drugs of this type to be used clinically. However, over the past 3 decades there has been a dramatic increase in the number of NSAIDs available for the treatment of postoperative pain. Tissue injury, such as occurs with surgical intervention, is associated with the release of numerous inflammatory mediators including prostaglandins. Prostaglandins derived from the arachidonic acid cascade are implicated in the production of inflammatory pain, and in sensitising nociceptors to the actions of other mediators. They are synthesised from arachidonic acid via the endoperoxide biosynthesis pathway, the initial step of which is catalysed by the enzyme cyclo-oxygenase. Two forms of the cyclo-oxygenase enzyme (COX-1 and COX-2) have been characterised. COX-1 is important in circumstances where prostaglandins have a protective effect such as gastric mucus production and renal blood flow maintenance. NSAIDs inhibit the synthesis of prostaglandins at 1 or more points in the endoperoxide pathway. Three mechanisms of inhibition of the biosynthetic enzymes have been proposed: (i) rapid, reversible competitive inhibition; (ii) irreversible, time-dependent inhibition; and (iii) rapid, reversible noncompetitive (free radical trapping) inhibition. In addition, there is evidence that NSAIDs have a central antinociceptive mechanism of action that augments the peripheral effect. This may involve inhibition of central nervous system prostaglandins or inhibition of excitatory amino acids or bradykinins. There is considerable variability in the pain relief obtained from NSAIDs. Such variability in drug response may be explained in terms of differences between agents with respect to either pharmacodynamic actions or pharmacokinetic parameters or a combination of both. Stereoisomerism, where preparations exist as racemic mixtures and where only 1 enantiomer is active, may also be important. However, chiral inversion from inactive to active enantiomer may occur and may be rapid or slow. NSAIDs have numerous adverse effects. Gastrointestinal disturbances including ulceration are the commonest adverse responses to NSAIDs and carry the greatest risk of death. Also significant are renal impairment and an increased risk of postoperative haemorrhage. Asthma and allergic reactions are uncommon.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705216     DOI: 10.2165/00003495-199549010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  108 in total

1.  Variations in response to non-steroidal anti-inflammatory drugs.

Authors:  R O Day; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

2.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

3.  Intravenous indomethacin or oxycodone in prevention of post-operative pain.

Authors:  M A Mattila; E Ahlström-Bengs; P Pekkola
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

4.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

5.  Central and peripheral antialgesic action of aspirin-like drugs.

Authors:  S H Ferreira; B B Lorenzetti; F M Corrêa
Journal:  Eur J Pharmacol       Date:  1978-12-15       Impact factor: 4.432

6.  Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders.

Authors:  N Baber; L D Halliday; W J van den Heuvel; R W Walker; R Sibeon; J P Keenan; T Littler; M L Orme
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

7.  A multiple-dose comparison of ketorolac tromethamine with diflunisal and placebo in postmeniscectomy pain.

Authors:  W J Honig; J Van Ochten
Journal:  J Clin Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.126

8.  Pain relief after major gynaecological surgery.

Authors:  P E Lovett; S L Stanton; D Hennessy; J N Cashman
Journal:  Br J Nurs       Date:  1994 Feb 24-Mar 9

Review 9.  Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics.

Authors:  G A Higgs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Clinical pharmacokinetics of salicylates: a re-assessment.

Authors:  G Levy
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

View more
  13 in total

Review 1.  Maximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach.

Authors:  K S Ong; R A Seymour
Journal:  Anesth Prog       Date:  2003

Review 2.  Chirality and nonsteroidal anti-inflammatory drugs.

Authors:  P J Hayball
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 4.  WITHDRAWN: Diclofenac for acute pain in children.

Authors:  Joseph F Standing; Imogen Savage; Deborah Pritchard; Marina Waddington
Journal:  Cochrane Database Syst Rev       Date:  2015-07-02

Review 5.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Ibuprofen as a pre-emptive analgesic is as effective as rofecoxib for mandibular third molar surgery.

Authors:  Zac Morse; Anna Tump; Ester Kevelham
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

Review 7.  Clinical pharmacokinetics of dexketoprofen.

Authors:  M J Barbanoj; R M Antonijoan; I Gich
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  The effects of paracetamol, ketorolac, and paracetamol plus morphine on pain control after thyroidectomy.

Authors:  Sun Yeul Lee; Won Hyung Lee; Eun Ha Lee; Kyu Cheol Han; Young Kwon Ko
Journal:  Korean J Pain       Date:  2010-05-31

9.  A Comparative Efficacy of Propacetamol and Ketorolac in Postoperative Patient Controlled Analgesia.

Authors:  Bong Ha Heo; Ji Hun Park; Jung Il Choi; Woong Mo Kim; Hyoung Gon Lee; Soo Young Cho; Myoung Ha Yoon
Journal:  Korean J Pain       Date:  2015-07-01

Review 10.  Intravenous paracetamol reduces postoperative opioid consumption after orthopedic surgery: a systematic review of clinical trials.

Authors:  Bright Jebaraj; Souvik Maitra; Dalim Kumar Baidya; Puneet Khanna
Journal:  Pain Res Treat       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.